TrialAmerican journal of hematology2010
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
Martin H Steinberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
232 papers cite itlatest 60 shown
this paperpooled ittrialcites it